News & Analysis on Clinical Trial Services & Contract Research And Development
By Melissa Fassbender
- Last updated on
The consultancy has named Claire Scruton as the new senior manager of CMC regulatory affairs.
She will in this role provide strategic regulatory CMC advice and operational support across a range of therapeutic areas and development stages for ATMPs, biologics, and new chemical entities, according to the company.
Scruton has more than 20 years of experience in the pharmaceutical industry, with a background in biological and inhalation product development, and joins Boyds from Mundipharma, before which she was at Pfizer for 13 years.